Atlas Trials

A Safety Study of IMOVAX Polio Vaccine in Selected Cities in China

Clinical trial NCT01278433 · COMPLETED

Trial details

NCT number
NCT01278433
Sponsor
Sanofi Pasteur, a Sanofi Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
PolioPoliomyelitis
Start date
2010-12-01
Primary completion
2011-12-01
Enrollment
5007

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.